Clinical Trial Update: Intranasal Dexmedetomidine Versus Intranasal Midazolam for Emergence Delirium Prevention [Phase 4]

View source ↗

Summary

Phase 4 trial comparing intranasal dexmedetomidine to intranasal midazolam for prevention of emergence delirium.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Emergence Delirium

Drugs mentioned

• Dexmedetomidine (intranasal) (dexmedetomidine)
• Midazolam (intranasal) (midazolam)

Snippet

Sponsor: Indonesia University | Conditions: Emergence Delirium | Phase 4 | Status: COMPLETED